Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 7.

Pulkovski, N; Mannion, A F; Caporaso, F; Toma, V; Gubler, D; Helbling, D; Sprott, H (2012). Ultrasound assessment of transversus abdominis muscle contraction ratio during abdominal hollowing: a useful tool to distinguish between patients with chronic low back pain and healthy controls? European Spine Journal, 21(S6):750-759.

Gubler, D; Mannion, A F; Schenk, P; Gorelick, M; Helbling, D; Gerber, H; Toma, V; Sprott, H (2010). Ultrasound tissue Doppler imaging reveals no delay in abdominal muscle feed-forward activity during rapid arm movements in patients with chronic low back pain. Spine, 35(16):1506-1513.

Rochlitz, C; Senn, H-J; Betticher, D; Helbling, D; von Moos, R; Pestalozzi, B; Thürlimann, B; Uebelhart, D; Aapro, M (2010). Der Einsatz von Bisphosphonaten bei der Behandlung solider Tumoren. Swiss Medical Forum, 10(34):562-564.

Cathomas, R; Helbling, D; Stenner, F; Rothermundt, C; Rentsch, C; Shahin, O; Seifert, H-H; Zaugg, K; Lorch, A; Mayer, F; Beyer, J; De Santis, M; Gillessen, S (2010). Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effort. Swiss Medical Weekly, 140(25-26):356-369.

Lübbe, J; Anliker, M; Bernier, J; Borner, M; Dummer, R; Helbling, D; Hohl, D; Hunziker, T; Itin, P; Köberle, D; Pestalozzi, B; Rauch, D; Surber, C (2009). Kutane Nebenwirkungen der Therapie mit EGFR-Inhibitoren Klinische Einteilung und Behandlung. Dermatologica Helvetica, (5):19-23.

Mannion, A F; Helbling, D; Pulkovski, N; Sprott, H (2009). Spinal segmental stabilisation exercises for chronic low back pain: programme adherence and its influence on clinical outcome. European Spine Journal, 18(12):1881-1891.

Borner, M; Koeberle, D; Von Moos, R; Saletti, P; Rauch, D; Hess, V; Trojan, A; Helbling, D; Pestalozzi, B; Caspar, Christian; Ruhstaller, T; Roth, A; Kappeler, A; Dietrich, D; Lanz, D; Mingrone, W (2008). Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the swiss group for clinical cancer research SAKK. Annals of Oncology, 19(7):1288 -1292 .

This list was generated on Mon Nov 20 16:43:29 2017 CET.